These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34044876)

  • 1. The emerging role of RNA N6-methyladenosine methylation in breast cancer.
    Zheng F; Du F; Zhao J; Wang X; Si Y; Jin P; Qian H; Xu B; Yuan P
    Biomark Res; 2021 May; 9(1):39. PubMed ID: 34044876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.
    Zheng F; Du F; Qian H; Zhao J; Wang X; Yue J; Hu N; Si Y; Xu B; Yuan P
    Biomark Res; 2021 Apr; 9(1):28. PubMed ID: 33926554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging function of N6-methyladenosine in cancer.
    Hong K
    Oncol Lett; 2018 Nov; 16(5):5519-5524. PubMed ID: 30344705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
    Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
    Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications.
    Luo J; Xu T; Sun K
    Front Cell Dev Biol; 2021; 9():670711. PubMed ID: 34150765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.
    Chen X; Xie Y; Liu Q; Luo X; Gao Y
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):304. PubMed ID: 36472104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of RNA N
    Zheng X; Gong Y
    Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
    Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
    Front Oncol; 2022; 12():970833. PubMed ID: 36226062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
    Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
    Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer.
    Ma M; Ye T; Wang J; Zhao H; Zhang S; Li P; Zhao G
    Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36553003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A readers
    Anita R; Paramasivam A; Priyadharsini JV; Chitra S
    Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
    Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
    Front Surg; 2022; 9():819335. PubMed ID: 35155557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma.
    Xu N; Chen J; He G; Gao L; Zhang D
    J Cancer; 2020; 11(17):5187-5197. PubMed ID: 32742465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases.
    Chen X; Wang J; Tahir M; Zhang F; Ran Y; Liu Z; Wang J
    Cell Biosci; 2021 Jul; 11(1):147. PubMed ID: 34315538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
    Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
    Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of m6A RNA Methylation in Ischemic Stroke.
    Xu Y; Liu W; Ren L
    Mol Neurobiol; 2024 Sep; 61(9):6997-7008. PubMed ID: 38363537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
    Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
    Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A RNA methylation regulators contribute to malignant development and have a clinical prognostic effect on cervical cancer.
    Ma X; Li Y; Wen J; Zhao Y
    Am J Transl Res; 2020; 12(12):8137-8146. PubMed ID: 33437387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.